Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Poietis is a French biotechnology company at the forefront of 4D bioprinting technology. Founded in 2014, the company specializes in designing, developing, and manufacturing bioprinters and bioprinted human tissues for applications in regenerative medicine, pharmaceutical research, and cosmetics testing. Their proprietary laser-assisted bioprinting technology allows for high precision and cell viability in creating complex tissue structures. Poietis aims to provide disruptive solutions for tissue engineering, offering alternatives to animal testing and paving the way for personalized therapeutic treatments.
Primary center for research and development of 4D bioprinting technology, manufacturing of NGB (Next Generation Bioprinting) systems and bioprinted tissues (e.g., Poieskin®), and central corporate operations.
State-of-the-art bioprinting laboratories, ISO-certified cleanroom facilities, and its strategic location within the Bioparc Pessac, a campus dedicated to health and life sciences innovation.
A highly innovative and research-intensive environment, fostering collaboration among scientists, engineers, and business professionals. The culture is characterized by a strong focus on scientific rigor, technological advancement, and a shared mission to impact regenerative medicine and drug development.
The Pessac headquarters is the nerve center of Poietis's pioneering work in bioprinting, housing its core R&D, production, and strategic decision-making. Its location within a biotech hub facilitates collaborations and access to talent.
While headquartered in France, Poietis supports functions globally through strategic partnerships and direct client engagement. This includes the distribution of its NGB bioprinting systems and Poieskin® tissue models, collaborative research projects with international pharmaceutical and cosmetic companies, and providing technical support and expertise to its worldwide customer base. Their technology is utilized by researchers and industries in various countries aiming to advance drug discovery, dermo-cosmetics, and regenerative medicine.
Bioparc, 27 Allée Charles Darwin
Pessac
Nouvelle-Aquitaine
France
Address: N/A - Operations are centralized with global reach managed through partnerships
To facilitate international sales of NGB bioprinting platforms, distribution of bioprinted tissue models like Poieskin®, and establish research collaborations with pharmaceutical companies, academic institutions, and cosmetic industries across key markets in North America, Europe, and Asia.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Poietis' leadership includes:
Poietis has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major C-suite executive hires or exits announced by Poietis in the last 12 months. The current leadership team appears stable, guiding the company's strategic initiatives and technological advancements.
Discover the tools Poietis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Poietis likely uses common corporate email formats. A frequently observed pattern for companies of its size and structure is the [first_initial][last]@[domain] or [first].[last]@[domain] format.
[first_initial][last]@poietis.com
Format
bbrisson@poietis.com
Example
88%
Success rate
poietis.com • November 14, 2023
Poietis and McDermott Will & Emery have entered into a strategic partnership to navigate and advance the regulatory pathways for 3D bioprinted tissues, aiming to accelerate their adoption in therapeutic applications....more
poietis.com • November 7, 2023
Poietis announced that its NGB-R™ (Next Generation Bioprinting - Research) platform has received CE marking, signifying compliance with European standards for research equipment and enabling its commercialization for laboratory use....more
poietis.com • June 20, 2023
Poietis has launched Poieskin®, its first commercial bioprinted human full-thickness skin model. This advanced tissue model, created using 4D bioprinting, is designed for dermo-cosmetic and pharmaceutical research, offering an alternative to animal testing....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Poietis, are just a search away.